BioSpace News Archive

Scitara joins BioPhorum global collaboration to drive scientific advancements in biopharmaceutical sector

Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements.

January 31, 2022
·
3 min read
BioCapital

Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine

Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.

January 31, 2022
·
6 min read
BioCapital

Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine

Novavax, Inc. today announced that it has submitted a request to the U.S Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for NVX-CoV2373.

January 31, 2022
·
8 min read
Business

Inventiva receives a €4 million milestone payment from AbbVie for cedirogant Phase IIb initiation

Inventiva today announced the receipt of a €4 million milestone payment from AbbVie.

January 31, 2022
·
9 min read
Business

Replimune Announces the Departure of Dr. Otello Stampacchia from its Board of Directors

Replimune Group Inc. today announced Otello Stampacchia, Ph.D., of Omega Funds, has resigned from the company’s Board of Directors.

January 31, 2022
·
3 min read
Bio NC

Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition

Sio Gene Therapies Inc. today provided a corporate update announcing the prioritization of AXO-AAV-GM1 and AXO-AAV-GM2, its clinical stage AAV gene therapy programs for GM1 and GM2 gangliosidosis (Tay-Sachs/Sandhoff disease).

January 31, 2022
·
8 min read
Deals

Sierra Oncology Announces Closing of Upsized Public Offering of $135.0 Million of Securities

Sierra Oncology, Inc. today announced the closing of its previously announced underwritten public offering of 4,074,075 shares of its common stock at a price to the public of $27.00 per share.

January 31, 2022
·
3 min read
Business

Oxford Biomedica announces update to agreement with Sio Gene Therapies

Oxford Biomedica plc announced today that it was informed on Monday 31 January by Sio Gene Therapies (Sio) that Sio intends to return the global rights for AXO-Lenti-PD and that they intend to cease work on this gene therapy programme in Parkinson’s Disease.

January 31, 2022
·
3 min read
Business

NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer

NuVasive, Inc. today announced the appointment of Andrew (Drew) C. Morton as senior vice president and chief human resources officer (CHRO) effective February 7, 2022 .

January 31, 2022
·
3 min read
Business

Systemic Therapeutics Announces the Appointment of Its Executive Team

SystemicTx is pleased to announce the appointment of its executive team, characterized by deep experience and proven track records of building and scaling businesses and drug developments across a variety of industries.

January 31, 2022
·
6 min read